GlassScriptPhysician profile
James D Duncan
NPI 1598725020
$2,470.94
in general payments reported to CMS, 2019-2025
36 companies · $834 in 2025
The $834 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2020: $153 · 2021: $143 · 2022: $96.85 · 2023: $267 · 2024: $528 · 2025: $834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,629.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $402.16 | 2022-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $280.52 | 2022-2025 | Rexulti, Nuedexta |
| Pfizer INC. | $163.10 | 2019-2023 | |
| Axsome Therapeutics, INC. | $118.86 | 2023-2025 | Auvelity |
| Vanda Pharmaceuticals INC. | $114.25 | 2025 | Fanapt |
| Biohaven Pharmaceuticals, INC. | $112.14 | 2021 | |
| Corium, LLC | $110.59 | 2022-2025 | Azstarys |
| Abbvie INC. | $109.12 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.50 | 2024-2025 | Jardiance |
| Lilly USA, LLC | $76.67 | 2020-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $75.71 | 2019-2022 | |
| Lundbeck LLC | $72.79 | 2022-2024 | Rexulti |
| Sunovion Pharmaceuticals INC. | $62.93 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $62.41 | 2019 | |
| Exact Sciences Corporation | $59.30 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Duncan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.